GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Schott Pharma AG & CO KGaA (WBO:1SXP) » Definitions » Additional Paid-In Capital

Schott Pharma AG KGaA (WBO:1SXP) Additional Paid-In Capital : €494.5 Mil(As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Schott Pharma AG KGaA Additional Paid-In Capital?


Schott Pharma AG KGaA's quarterly additional paid-in capital stayed the same from Jun. 2024 (€494.5 Mil) to Sep. 2024 (€494.5 Mil) and stayed the same from Sep. 2024 (€494.5 Mil) to Dec. 2024 (€494.5 Mil).

Schott Pharma AG KGaA's annual additional paid-in capital increased from Sep. 2022 (€0.0 Mil) to Sep. 2023 (€494.5 Mil) but then stayed the same from Sep. 2023 (€494.5 Mil) to Sep. 2024 (€494.5 Mil).


Schott Pharma AG KGaA Additional Paid-In Capital Historical Data

The historical data trend for Schott Pharma AG KGaA's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Schott Pharma AG KGaA Additional Paid-In Capital Chart

Schott Pharma AG KGaA Annual Data
Trend Sep20 Sep21 Sep22 Sep23 Sep24
Additional Paid-In Capital
- - - 494.48 494.48

Schott Pharma AG KGaA Quarterly Data
Sep20 Sep21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 494.48 494.48 494.48 494.48 494.48

Schott Pharma AG KGaA Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Schott Pharma AG KGaA Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Schott Pharma AG KGaA's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Schott Pharma AG KGaA Business Description

Traded in Other Exchanges
Address
Hattenbergstrasse 10, Mainz, RP, DEU, 55122
Schott Pharma AG & CO KGaA caters to the pharma, biotech and life science industry by providing containment solutions and delivery systems for injectable drugs. Its segments include; Drug Containment Solutions (DCS) and Drug Delivery Systems (DDS). The majority of the revenue is generated from Drug Containment Solutions segment which includes products like vials, cartridges and ampoules for safe drug containment. Geographically, the company generates revenue from Europe, Middle East, Africa (EMEA), Asia and South Pacific, North America and South America.

Schott Pharma AG KGaA Headlines

No Headlines